Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 4:00 PM
Ignite Modification Date:
2025-12-26 @ 4:00 PM
NCT ID:
NCT05583006
Eligibility Criteria:
Inclusion Criteria:
1. At least 20 years of age
2. Detectable serum HBsAg
3. Chronic HBV infection under ETV therapy
4. ETV users who are unsatisfied with the efficacy and/or feel inconvenient of ETV therapy
5. No contraindications for TAF switch therapy
6. HBV antiviral period expectancy for at least 1 year
Exclusion Criteria:
1. End stage renal disease (estimated glomerular filtration rate \[eGRF\]\< 15 mL/min/1.73m2) without dialysis
2. Co-infected with human immunodeficiency virus, hepatitis C virus, or hepatitis D virus
3. Any active malignancies
4. Under immunosuppressants
5. Known allergy to tenofovir-contained regimens
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT05583006
Study Brief:
Protocol Section:
NCT05583006